(VIANEWS) – Align Technology (ALGN) shares have seen a notable 24.32% surge over the past 10 sessions, rising from EUR218.69 to EUR271.87 despite overall market gains of 0.19% to EUR14,992.97. Interestingly, while ALGN’s closing price of EUR271.87 represents a 34.2% decrease from its 52-week high of EUR413.20; this recent price increase may be related to factors like positive company news or market sentiment or wider economic trends – therefore investors should stay informed when making investment decisions – as it’s imperative they consult multiple sources when making decisions related to investment decisions relating to ALGN shares.
About Align Technology
Align Technology, Inc. specializes in designing, manufacturing and marketing clear aligners and intraoral scanners to orthodontists and general practitioner dentists throughout the US, Switzerland, China and internationally. Our business operates in two areas: Clear Aligner and Imaging Systems and CAD/CAM Services (Systems and Services). Clear Aligner products cover both comprehensive and non-comprehensive solutions for dental professionals, teens and younger children – such as Invisalign for teenagers – retention products and dental professional training courses. Systems and Services provides intraoral scanning systems from iTero, restorative software for general practitioner dentists, as well as digital record storage software and orthodontic diagnosis software to orthodontists. Align Technology Inc was founded in 1997 and is headquartered in Tempe, Arizona. Additionally, this segment provides Invisalign outcomes simulator, progress assessment tool, TimeLapse technology subscription software disposable rentals leases pay per scan services as well as various subscription software disposable rentals leases pay per scan services.
Yearly Analysis
Based on this information, Align Technology’s stock is currently trading at EUR271.87 – significantly below its 52-week high of EUR413.20 but higher than its 52-week low of EUR176.34. This indicates that it may have been overvalued previously but may now be trading undervalued.
Align Technology anticipates experiencing moderate sales growth of 2.6% this year and slightly greater expansion over the next 12 months – this growth rate matches up perfectly with market expectations.
Align Technology currently boasts an EBITDA ratio of 5.17, which indicates healthy profitability and suggests the company is making reasonable returns.
Investors considering Align Technology at its current price may wish to do further research before making any investment decisions, given its undervalued status and moderate growth prospects. It is essential to remember that past performance doesn’t guarantee future results and investors should conduct thorough analysis prior to making their final investment decision.
Technical Analysis
Align Technology’s stock appears to be on a downward trend, as its value falls below both its 50-day and 200-day moving averages. While this could signal that its performance may be declining, moving averages can simply serve to smooth out price data and identify trends.
Today’s reported volume of 895,303 represents 28.09% below the stock’s average daily volume of 1,245,200 and indicates relatively lower trading activity currently. This could indicate either lack of interest from traders or uncertainty around future outcomes for this stock.
Looking at the stock’s volatility, we can see that its intraday variation average over the past week, month, and quarter has been relatively low – between 0.98% to 2.42% over that timeframe. Its highest amplitude was 2.58% for its intraday variation average last week; 2.58% in its intraday variation average over month 1 and quarter 1. This suggests the stock has been relatively steady in price though it may have experienced some fluctuations over time.
Finally, Align Technology’s stock has reached oversold levels on the stochastic oscillator (=20). This indicates that its valuation may be understated and may even experience future gains; however it should be remembered that this indicator should only be relied upon as part of overall investment decisions and should not be solely relied upon when making them.
Quarter Analysis
According to Align Technology’s sales data, its current quarter sales growth stands at 3.7% and will decrease to 0.3% for its subsequent quarter; however, Align’s projected quarterly sales increases are much higher at 24.9% and 13.2%, respectively.
Additionally, year-on-year quarterly revenue growth was positive at 7.8% for the twelve trailing month period ending September 2015.
Overall, the company’s growth projections look strong despite a slight slowdown in sales growth for the next quarter. Strong estimates for both current and upcoming quarters point toward positive revenue growth for some time; however, investors must remember that investing in stocks involves risk. Before making any financial decisions in any investment portfolio.
Equity Analysis
Align Technology currently generates an EPS of EUR4.73 per share over its trailing twelve month period, reflecting shareholder profits totalling EUR4.73.
Align Technology boasts a trailing twelve months price to earnings ratio of 57.48, which is quite high. This indicates that investors who purchase shares may be investing roughly one euro of annual earnings into each euro of return for which they receive payment from Align Technology – this suggests they are likely paying more for this stock, signalling greater expectations for growth moving forward.
Return on Equity (ROE), which measures profitability relative to shareholder’s equity, for the past twelve months is 9.68%, meaning that this company generated a return of 9.68% on shareholder’s investments.
Overall, Align Technology appears to be a profitable company with an attractive valuation. The high PE ratio suggests investors’ optimism regarding future growth prospects for Align Tech; however, any potential investors must carefully assess its financial performance, growth potential and market trends before making their own investment decision.
More news about Align Technology (ALGN).
